Publications by authors named "Jeff P Armitstead"

Article Synopsis
  • Positive airway pressure (PAP) is the primary treatment for obstructive sleep apnea (OSA), but its effectiveness in real-world situations is often challenged due to patient adherence issues.* -
  • A study analyzed data from over 95,000 U.S. patients using the myAir app, observing that most patients reported improved sleepiness after using PAP therapy, particularly after 28 days.* -
  • The research found a strong connection between reduced sleepiness and consistent PAP usage, indicating that better self-reported sleepiness is linked with increased compliance and usage over time.*
View Article and Find Full Text PDF

Study Objectives: There is a complex interplay between obstructive sleep apnea (OSA) and type 2 diabetes. There are minimal data regarding the effects of treating OSA with positive airway pressure (PAP) therapy on outcomes and health care resource utilization (HCRU) in patients with OSA and type 2 diabetes. We investigated the impact of PAP adherence on HCRU and costs in this population.

View Article and Find Full Text PDF

The co-occurrence of obstructive sleep apnea and chronic obstructive pulmonary disease, termed overlap syndrome, has a poor prognosis. However, data on positive airway pressure (PAP) treatments and their impact on outcomes and costs are lacking. This retrospective observational study investigated the effects of PAP on health outcomes, resource usage, and costs in patients with overlap syndrome.

View Article and Find Full Text PDF

Study Objectives: Minimal focus has been placed on variations in health care delivery for obstructive sleep apnea (OSA). This study compared positive airway pressure usage in developing countries (Brazil and Mexico) vs. a developed country (United States) and investigated the impact of a patient engagement tool (myAir; ResMed, San Diego, CA) on adherence.

View Article and Find Full Text PDF

Study Objectives: There is a lack of data regarding adherence trajectories when switching from continuous positive airway pressure (CPAP) to adaptive servoventilation (ASV) in the context of persistent or treatment-emergent central sleep apnea (CSA). This study investigated 90-day adherence rates in patients with sleep apnea based on the type of positive airway pressure (PAP) device used and any switching of PAP modality over time.

Methods: Telemonitoring data were obtained from a United States PAP database.

View Article and Find Full Text PDF